Information Provided By:
Fly News Breaks for February 8, 2018
RXN
Feb 8, 2018 | 06:47 EDT
Oppenheimer analyst Jim Giannakouros upgraded Rexnord to Outperform from Perform with a $33 price target. The analyst likes Rexnord's prospects for growth acceleration and "enhanced" margin progression following its "upbeat" earnings call and guidance. He sees the shares continuing to appreciate over the intermediate term and recommends taking advantage of the recent pullback.
News For RXN From the Last 2 Days
There are no results for your query RXN